Barrett’s oesophagus: diagnosis and managementBMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2373 (Published 11 May 2016) Cite this as: BMJ 2016;353:i2373
- Prachi Pophali, research fellow1,
- Magnus Halland, gastroenterologist1
- 1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester MN 55905, USA
- Correspondence to: M Halland
What you need to know
Barrett’s oesophagus is the asymptomatic replacement of normal squamous epithelium of oesophagus by metaplastic columnar epithelium
It is a precursor for oesophageal adenocarcinoma
Gastro-oesophageal reflux disease (GORD) is strongest risk factor known and should be managed by optimising lifestyle factors and proton pump inhibitor therapy
For non-dysplastic Barrett’s oesophagus with intestinal metaplasia or any Barrett’s oesophagus >3 cm in length, treat GORD symptoms and perform endoscopic surveillance every 3-5 years
If dysplasia or neoplasia is confirmed on endoscopy, treatment options include endoscopic mucosal resection or radiofrequency ablation
Barrett’s oesophagus is a premalignant condition where the oesophageal squamous epithelium undergoes columnar change with metaplasia which predisposes to the development of oesophageal adenocarcinoma. In order for Barrett’s oesophagus to be diagnosed, a segment of the lower oesophagus has to be replaced by columnar tissue (fig 1⇓). In patients with oesophageal columnar tissue without intestinal metaplasia the cancer risk is thought to be low. Many patients with Barrett’s oesophagus have no symptoms. Development of oesophageal adenocarcinoma is understood to progress in a stepwise manner following the sequence of oesophagitis, metaplasia, dysplasia, and finally adenocarcinoma (fig 2⇓). This review describes how Barrett’s oesophagus is diagnosed and explores questions regarding current and future management strategies for Barrett’s oesophagus.
We searched PubMed, Medline, and the Cochrane database from inception to November 2015 using the primary search terms “Barrett’s oesophagus,” “Barrett’s management,” and “endoscopic therapy for Barrett’s.” Abstracts published in English were included. Priority was given to randomised controlled trials and meta-analyses; citations from case series and retrospective studies were included where appropriate.
How many people have Barrett’s oesophagus?
The prevalence of Barrett’s oesophagus ranges varies widely in the general population depending on the definition of diagnosis and …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial